OMOPRUBART
UNII 2YUH7KM2C2

Substance Identification & Data

This profile provides standardized clinical and technical data for Omoprubart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2YUH7KM2C2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2763342-87-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2YUH7KM2C2

CAS Registry Number

2763342-87-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OMOPRUBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203145

National Cancer Institute reference terminology for clinical and research data.

INN ID

12638

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Omoprubart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OMOPRUBART

Common Names & Synonyms

GAMMA2/GAMMA4 HEAVY CHAIN (1-448) (VH (HOMO SAPIENS IGHV1-2*06 (85.7%) -(IGHD) -IGHJ4*01(93.3%), CDR-IMGT (8.8.15) (26-33.51-58.97-111)) (1-122) -HOMO SAPIENS IGHG2*01 CH1-HINGE (CH1 (123-220), HINGE 1-15 (221-232)) -HOMO SAPIENS IGHG4*01CH2-CH3, NG4M(A) CH2 L92, G4V7 CH2 DELE1.4, P1.3, V1.2, A1.1, G4V21 CH2 Y15.1, T16, E18 (CH2 L92 (310)E1.4>DEL, F1.3>P (235), L1.2>V (236), G1.1>A (237), M>Y15.1 (253), S>T16 (255), T>E18(257)(233-341), CH3 (342-446), CHS (447-448)) (123-448)), (136-214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (77.9%)-IGKJ3*01 (81.8%) P120>G (100'), CDR-IMGT (6.3.9)(27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (153'), V101 (191') (108'-214')); DIMER (224-224'':225-225'':228-228'':231-231'')-TETRAKISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS

IMMUNOGLOBULIN G (27-HISTIDINE,57-HISTIDINE,253-TYROSINE,255-THREONINE,257-GLUTAMIC ACID), ANTI-(HUMAN COMPLEMENT C5) (HUMAN MONOCLONAL CAN106 HYBRID .GAMMA.2-CHAIN CH1-HINGE REGION/.GAMMA.4-CHAIN CH2-CH3 REGION), DISULFIDE WITH HUMAN MONOCLONAL CAN106 .KAPPA.-CHAIN, DIMER

MMUNOGLOBULIN G2/G4-KAPPA, ANTI-(HOMO SAPIENS C5 (COMPLEMENT 5)), MONOCLONAL ANTIBODY

OMOPRUBART [INN]

OMOPRUBART [WHO-DD]